Published in J Pharm Pharmacol on October 01, 2005
Adaptive therapy. Cancer Res (2009) 2.81
New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug. Mol Pharm (2007) 1.33
Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. Biomaterials (2008) 1.12
Near-infrared-resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic agent. Small (2010) 1.03
E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J Control Release (2012) 0.97
Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model. Cancer Gene Ther (2007) 0.95
Development and in vitro-in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer. Pharm Res (2011) 0.94
Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes. J Nanomater (2012) 0.90
Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth. Mol Pharm (2010) 0.89
Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel. Int J Mol Sci (2011) 0.87
A reductive cyclization approach to attenol A. J Org Chem (2007) 0.87
Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors. J Ther Ultrasound (2013) 0.84
Mucoadhesive fenretinide patches for site-specific chemoprevention of oral cancer: enhancement of oral mucosal permeation of fenretinide by coincorporation of propylene glycol and menthol. Mol Pharm (2012) 0.82
Over-pressure suppresses ultrasonic-induced drug uptake. Ultrasound Med Biol (2008) 0.80
Assembly of bio-nanoparticles for double controlled drug release. PLoS One (2013) 0.80
Controlled block copolymer micelle formation for encapsulation of hydrophobic ingredients. Eur Phys J E Soft Matter (2013) 0.77
Investigation of cyanine dyes for in vivo optical imaging of altered mitochondrial membrane potential in tumors. Cancer Med (2014) 0.75
Practical Issues with the Use of Stem Cells for Cancer Gene Therapy. Stem Cell Rev (2015) 0.75